Sigara Bırakmada Farmakoterapi
Y. Hakan Doğan, Serdar Demirgören
doaj
Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. [PDF]
Bedillion MF +5 more
europepmc +1 more source
Diet-dependent modulation of energy balance by CB1 signaling in peripheral sensory neurons. [PDF]
Linden B +15 more
europepmc +1 more source
Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG. [PDF]
Palomino SM +5 more
europepmc +1 more source
Exacerbated cardiac dysfunction from combined alcohol binge and synthetic cannabinoid use. [PDF]
Paloczi J +7 more
europepmc +1 more source
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice. [PDF]
James JC +6 more
europepmc +1 more source
<i>Cannabis</i> Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance. [PDF]
Żółnowska I +3 more
europepmc +1 more source
Synthesis and Pharmacological Characterization of Novel Peripheral Cannabinoid-1 Receptor Blockers Based on a Tricyclic Scaffold. [PDF]
Gammal A +8 more
europepmc +1 more source

